Liquid biopsy in precision oncology: Current insights and future perspectives
Abstract
Personalized oncology may be defined as an evidence-based patient-centric medicine that delivers accurate care to the cancer patient at the exact time which results in a cost-effective, quantifiable progress in treatment outcome with minimal toxicity. Liquid biopsy is progressing as an effective tool in precision oncology [Figure 1]. It enables noninvasive detection, disease characterization, and helps in real-time cancer monitoring. This review explores the merits, challenges, and recent advancements of liquid biopsy in personalized oncology. We discuss present clinical applications, their potentials, and future directions for integration into routine cancer care.
Fields of Study & Subjects
Cancer Genomics and Diagnostics
Cancer Diagnosis and Treatment
Extracellular vesicles in disease
Publication details
- Journal / source
- Indian Journal of Precision Medicine and Molecular Medicine
- Volume
- 2
- Issue
- 1
- Pages
- 22–30
- Publication date
- 1 January 2026
- Language
- EN